Reckitt Benckiser - Nurofen 12 Hour and Nuromol Dual Action Pain Relief

Therapeutic Goods Act 1989

Approval under section 42DF for use of restricted representations by Reckitt Benckiser Pty Ltd

I, Leanne McCauley, as a delegate of the Secretary to the Department of Health, on receipt of an application from Reckitt Benckiser Pty Ltd, have approved under section 42DF of the Therapeutic Goods Act 1989 (the Act) the restricted representation described in paragraph (A) below for use in advertisements directed to consumers, for the product identified in paragraph (B):

1.  
   • "The temporary relief of pain and/or inflammation associated with arthritis/osteoarthritis"
2.  
   • NUROFEN 12 HOUR (AUST R 335682)
   • NUROMOL DUAL ACTION PAIN RELIEF (AUST R 324967)

Dated this 21st day of May 2021

Signed electronically

Leanne McCauley
Delegate of the Secretary to the Department of Health
Advertising and Compliance Education and Policy Section
Regulatory Compliance Branch